🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main aim of the present study is to evaluate the clinical efficacy of f...
Status
Completed
Location
Soonchunhyang University Bucheon Hospital
Start Date
2010-03
Trial ID
NCT01004497
Treatments Being Tested
In December 2019, coronavirus pneumonia (COVID-19) was detected in many cas...
Status
Completed
Location
Xi'an International Medical Center Hospital
Start Date
2020-02-06
Trial ID
NCT04664010
Treatments Being Tested
The purpose of this study was to gather and evaluate additional safety and ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2018-02-13
Trial ID
NCT03379727
Treatments Being Tested
This is a randomized, open-label, multi-center, phase 3 study evaluating th...
Status
Unknown
Location
Ru Feng
Start Date
2017-07-27
Trial ID
NCT03018626
This open label, multicenter phase II/III study with multiple randomization...
Status
Recruiting
Location
CH Amiens Hôpital Sud
Start Date
2015-01
Trial ID
NCT02416388
Glasdegib is being studied in combination with azacitidine for the treatmen...
Status
Completed
Location
UCLA Department of Medicine
Start Date
2018-04-20
Trial ID
NCT03416179
Treatments Being Tested
This is a Phase Ib/IIa open-labeled multi-center trial evaluating the feasi...
Status
Completed
Location
Universitätsklinikum Innsbruck
Start Date
2009-06
Trial ID
NCT00850382
Treatments Being Tested
The current standard of care for the frontline treatment of peripheral T-ce...
Status
Terminated
Location
Brigham and Women's Hospital
Start Date
2013-07
Trial ID
NCT01746173
This study was conducted to explore a new therapy for anemia in participant...
Status
Completed
Location
Site BE32004
Start Date
2014-11-21
Trial ID
NCT02278341
Treatments Being Tested
This is a global Phase III, two-arm, open-label, multicenter, randomized st...
Status
Completed
Location
Maryland Oncology Hematology
Start Date
2018-06-14
Trial ID
NCT03493854